Corbus Pharmaceuticals Holdings Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

LSE:0SZI Recent Insider Transactions by Companies or Individuals
Date	Value	Name	Entity	Role	Shares	Max Price
06 Mar 25	SellUS$43,330	Dominic Smethurst	Individual		6,393	US$6.78
20 Sep 24	BuyUS$7,003,761	Cormorant Asset Management, LP	Company		350,000	US$22.23

Insider Trading Volume

Insider Buying: 0SZI insiders have only sold shares in the past 3 months.

Ownership Breakdown

What is the ownership structure of 0SZI?
Owner Type	Number of Shares	Ownership Percentage
Individual Insiders	40,727	0.333%
General Public	794,130	6.49%
VC/PE Firms	1,172,287	9.58%
Hedge Funds	3,490,000	28.5%
Institutions	6,739,623	55.1%

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.

Top Shareholders

Top 25 shareholders own 85.16% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
19.4%	Cormorant Asset Management, LP	2,375,000	US$17.4m	0%	1.4%
9.58%	OrbiMed Advisors LLC	1,172,287	US$8.6m	0%	0.14%
9.11%	Octagon Capital Advisors LP	1,115,000	US$8.2m	0%	1.62%
6.91%	BlackRock, Inc.	846,062	US$6.2m	-3.13%	no data
5.49%	The Vanguard Group, Inc.	672,057	US$4.9m	1.95%	no data
4.7%	Prosight Management, LP	575,136	US$4.2m	113%	1.39%
3.52%	RA Capital Management, L.P.	430,182	US$3.2m	0%	0.05%
3.27%	Paradigm Biocapital Advisors LP	399,658	US$2.9m	0%	0.14%
2.82%	Renaissance Technologies LLC	345,200	US$2.5m	148%	no data
2.37%	Exome Asset Management LLC	289,690	US$2.1m	0%	2.0%
2.22%	Geode Capital Management, LLC	271,514	US$2.0m	3.03%	no data
2.04%	Armistice Capital LLC	250,000	US$1.8m	5.93%	0.05%
1.83%	State Street Global Advisors, Inc.	223,470	US$1.6m	-2.24%	no data
1.63%	Comerica Bank, Banking Investments	200,001	US$1.5m	20,000,000%	0.01%
1.31%	Ghost Tree Capital, LLC	160,000	US$1.2m	0%	0.58%
1.05%	Mirae Asset Global Investments Co., Ltd.	129,043	US$947.2k	-20.8%	no data
1.04%	Driehaus Capital Management LLC	127,787	US$938.0k	0%	0.01%
1.04%	Tang Capital Management, LLC	127,520	US$936.0k	-47.5%	0.05%
0.99%	Two Sigma Investments, LP	121,164	US$889.3k	-9.7%	no data
0.87%	AQR Capital Management, LLC	106,054	US$778.4k	64.8%	no data
0.83%	Millennium Management LLC	101,607	US$745.8k	-73.7%	no data
0.82%	Northern Trust Global Investments	99,883	US$733.1k	-3.27%	no data
0.8%	Healthinvest Partners AB	98,304	US$721.6k	0%	0.32%
0.76%	Citadel Advisors LLC	92,991	US$682.6k	0%	no data
0.74%	UBS Asset Management AG	90,844	US$666.8k	1.64%	no data

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2025/05/19 06:18
End of Day Share Price	2025/05/16 00:00
Earnings	2025/03/31
Annual Earnings	2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Corbus Pharmaceuticals Holdings, Inc. is covered by 20 analysts. 8 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

Analyst	Institution
Kalpit Patel	B. Riley Securities, Inc.
George Zavoico	B. Riley Securities, Inc.
Kumaraguru Raja	Brookline Capital Markets